MedPath

A SINGLE BLIND, SINGLE DOSE STUDY OF THE SEDATIVE EFFECTS OF THIOCOLCHICOSIDE, TIZANIDINE AND CYCLOBENZAPRINE IN HEALTHY MALE, HUMAN VOLUNTEERS - TCC-C-001

Conditions
muscle spasm
MedDRA version: 9.1Level: HLGTClassification code 10028393Term: Musculoskeletal and connective tissue disorders NEC
Registration Number
EUCTR2008-004665-25-IT
Lead Sponsor
MUTUAL PHARMACEUTICAL COMPANY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

HEALTHY MALE VOLUNTEERS,18-40 YEARS, NORMAL HISTORY AND PHYSICAL EXAMINATION NORMAL LAB TESTS LESS THAN 18 UNITS ALCOHOL/WEEK WRITTEN INFORMED CONSENT
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

CURRENT ADMINISTRATION OF ANY MEDICATION ON A CHRONIC BASIS, CLINICALLY SIGNIFICANT CONCOMITANT SDIEASES, MORE THAN 10 SIGARETTE/DAY, INVESTIGAT.COMP,6 MONTH PRIOR TO STUDY, LACK OF INFORMED CONSENSE

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: EXTENT OF SEDATION INDUCED BY THE THREE STUDY DRUGS IN COMPARISON WITH PLACEBO;Secondary Objective: NONE;Primary end point(s): EXTENT OF SEDATION INDUCED BY THE THREE STUDY DRUGS IN COMPARISON WITH PLACEBO
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath